Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Australian class action suit filed against Johnson & Johnson over pelvic mesh

Published 04/07/2017, 07:09 pm
Updated 04/07/2017, 07:10 pm
© Reuters.  Australian class action suit filed against Johnson & Johnson over pelvic mesh
JNJ
-

By Ben Cooper

SYDNEY, July 4 (Reuters) - Australian women have brought a class-action case against Johnson & Johnson (NYSE:JNJ) JNJ.N over complications arising from vaginal mesh implants - a lawsuit that follows many others in the United States, Canada and Europe.

The claim, which is being heard in Australia's Federal Court, said patients had suffered chronic pain, bleeding and severe discomfort during sexual intercourse since having the mesh surgically implanted. The devices are used to treat stress urinary incontinence and pelvic organ prolapse.

The Australian action was brought on behalf of more than 700 claimants.

Johnson & Johnson said it was only aware of 200 "product events" after selling more than 100,000 pelvic floor repair products in Australia.

"It is always a concern to us when a patient doesn't get the outcome they had hoped for, or believes they have experienced an adverse event," spokeswoman Meshlin Khouri said in a statement.

"However it is important to remember that the majority of women who have undergone this surgery have had a positive result, and it has improved their quality of life."

Johnson & Johnson is one of several manufacturers that sold the devices. Those companies are facing tens of thousands of individual lawsuits from plaintiffs who said they were injured by the mesh's poor design and substandard materials.

In May, California accused Johnson & Johnson of failing to warn doctors and patients about the severity and frequency of complications associated with its pelvic mesh devices. Australian parliamentary committee is also holding an inquiry into the products and is expected to report its findings at the end of November.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.